10:00-16:00 | Excursion to Horyuji-Temple |
18:00-19:00 |
Keynote Address (Nikko Nara Hotel) Chairperson Dr. Nagahiro Saijo National Cancer Center Hospital East Speaker Prof. Giorgio V. Scagliotti University of Torino |
19:00-21:00 | Welcome Party Nikko Nara Hotel |
9:00-9:15 |
Opening Remark and Introduction WJTOG Prof. Masahiro Fukuoka Kinki University School of Medicine, Sakai Hospital |
9:15 |
Session I Molecular Targeted Therapy in Metastatic NSCLC I-1 Clinical trial of EGFR-TKI Chairpersons Dr. Rafael Rosell Hospital Germans Trias I Pujol Prof. Yoichi Nakanishi Kyushu University Graduate School of Medical Sciences |
9:15-9:35 |
Title:CALGB Trials with Molecular Targeted Therapy Speaker Prof. Everett E. Vokes University of Chicago |
9:35-9:45 |
Title:Prospective and Retrospective Study of Gefitinib in WJTOG (WJTOG0203A&0403) Speaker Dr. Kenji Tamura Kinki University School of Medicine, Nara Hospital |
9:45-10:00 |
Title:Korean Clinical Trials with Molecular Targeted Therapy Speaker Dr. Jin Soo Lee National Cancer Center Korea |
10:00-10:15 |
Title:Elrotinib monotherapy for Advanced NSCLC in Korea Speaker Dr. Keunchil Park Samsung Medical Center Korea |
10:15-10:45 |
Discussion Discussant Dr. Ikuo Sekine National Cancer Center Hospital Tokyo |
10:45 |
I-2 Biomarker & Clinical Trial Chairpersons Prof. Giorgio V. Scagliotti University of Torino Prof. Hirotoshi Akita Hokkaido University Graduate School of Medicine |
10:45-11:00 |
Title:Gefitinib and EGFR Mutations Speaker Dr. Tetsuya Mitsudomi Aichi Cancer Center Hospital |
11:00-11:20 |
Title:Biomarker & Clinical Trial Speaker Dr. Rafael Rosell Hospital Germans Trias i Pujol |
11:20-11:50 |
Discussant Prof. Kazuto Nishio Kinki University School of Medicine |
11:50 |
I-3 New Molecurar Targeted Agents for Lung Cancer Chairpersons Prof. Noriyuki Masuda Kitasato University School of Medicine Prof. Everett E. Vokes University of Chicago |
11:50-12:20 |
Title:New Molecular Targeted Agents for Lung Cancer (including bevacizumab) Speaker Prof. David R. Gandara University of California Davis Cancer Center |
12:20-12:50 |
Discussant Dr. Tomohide Tamura National Cancer Center Hospital Tokyo |
12:50-13:50 | Lunch |
13:50-14:45 |
Educational Lecture Title:Current Topics of Pathology in Lung Cancer Speaker Dr. William D.Travis Memorial Sloan Kettering Cancer Center |
14:45-15:00 | Break |
15:00 |
Section Meeting1 1-1 BAC & BAC Feature Chairpersons Dr. William D. Travis Memorial Sloan Kettering Cancer Center Dr. Hisao Asamura National Cancer Center Hospital |
15:00-15:20 |
Title:Pathological Concept of BAC Speaker Prof. Masayuki Noguchi Tsukuba University School of Medicine |
15:20-15:35 |
Title:Radiologic and Pathologic Correlations in Small Adenocarcinoma of The Lung Speaker Dr. Kenji Suzuki National Cancer Center Hospital Tokyo |
15:35-16:05 |
Discussion Discussant Dr. Riichiro Maruyama Nippon Steel Yawata Memorial Hospital |
16:05 |
1-2 Clinical Trials for BAC and BAC Feature Chairpersons Dr. Jin Soo Lee National Cancer Center Korea Dr. Minoru Takada NHO Kinki Cest Medical Center |
16:05-16:25 |
Title:Clinical Trials in Patients with Advanced BAC Speaker Prof. David R. Gandara University of California Davis Cancer Center |
16:25-16:50 |
Discussion Discussant Prof. Junya Fukuoka Toyama University Hospital |
15:00 |
Section Meeting 2 2-1 The role of PET for Clinical Trials Chairpersons Prof. Hak Choy University of Texas Southwestern Medical Center Prof. Kenji Eguchi Tokai University School of Medicine |
15:00-15:20 |
PET in Resectable NSCLC Title:Current position of PET on Resectable NSCLC Speaker Prof. Joe B. Putnam Vanderbilt University Medical Center |
15:20-15:50 |
Discussion Discussant Dr. Takashi Seto National Kyushu Cancer Center |
15:50 | 2-2 PET in Unresectable NSCLC |
15:50-16:10 |
Title:PET in RTOG Clinical Trial for Stage III NSCLC Speaker Dr. William T. Sause LDS Hospital |
16:10-16:25 |
Title:Current Clinical Status of PET in Europe Speaker Prof. Giorgio V. Scagliotti University of Torino |
16:25-16:50 |
Discussion Discussant Dr. Seiji Niho National Cancer Center Hospital East |
17:00-17:50 |
Japanese Lyrical Noh Drama |
18:00-20:30 |
Garden party was cancelled due to rainy climate. "KAGAMIWARI" ceremony, breaking up Sake barrels, by guest speakers. |
Dr. Kenji Tamura |
Dr. Ji-ichiro Sasaki |
9:00 |
SessionII II-1 Chemo-radiotherapy for Locally Advanced NSCLC Chairperson Prof. Kazushige Hayakawa Kitasato University School of Medicine Prof. Yasumasa Nishimura Kinki University School of Medicine II-1-1 Chemotherapy Regimen and Schedule |
9:00-9:20 |
Title:Clinical Trials for Locally Advanced NSCLC in USA Speaker Dr. William T. Sause LDS Hospital |
9:20-9:35 |
Title:Japanese Trials Speaker Dr. Nobuyuki Yamamoto Shizuoka Cancer Center |
9:35-10:05 |
Discussion Discussant Prof. Katsuyuki Kiura Okayama University Graduate School of Medicine and Dentistry |
10:05 | II-1-2 RT Technology: Dose and Schedule |
10:05-10:20 |
Title:Dose and Schedule of RT in Locally Advanced NSCLC (WJTOG3305) Speaker Dr. Takuhito Tada Osaka City University Medical School |
10:20-10:40 |
Title:Current Status of RT Technology in USA Speaker and Discussant Prof. Hak Choy University of Texas Southwestern Medical Center |
10:40-11:00 | Discussion |
11:00 |
II-2 Molecular Targeted Therapy for Locally Advanced NSCLC Chairperson Dr. William T. Sause LDS Hospital Prof. Satoshi Ishikura National Cancer Center Hospital East II-2-1 EGFR-TKIs |
11:00-11:20 |
Title:SWOG0023 Speaker Prof. David H. Gandara University of California Davis Cancer Center |
11:20-11:35 |
Title:JOCG Trials of Gefitinib in Combination with RT Speaker Dr. Yuichiro Ohe National Cancer Center Hospital Tokyo |
11:35-12:05 |
Discussion Discussant Dr. Isamu Okamoto Kinki University School of Medicine |
12:05 | II-2-2 EGFR/VEGF Antibodies |
12:05-12:25 |
Title:Clinical Trials of EGFR/VEGF Ab in Combination with RT Speaker Prof. Hak Choy University of Texas Southwestern Medical Center |
12:25-12:55 |
Discussion Discussant Dr. Kaoru Kubota National Cancer Center Hospital East |
12:55-14:00 |
Lunch |
14:00 |
SessionIII Peri-operative Chemotherapy in Early Stage NSCLC III-1 Clinical Imprecations of CALGB 9633 Chairperson Dr. Haruhiko Kondo Shizuoka Cancer Center Prof. Joe B. Putnam Vanderbilt University Medical Center |
14:00-14:15 |
Title:CALGB Trials in Early Stage NSCLC Speaker Prof. Everett E. Vokes University of Chicago |
14:15-14:25 |
Comment Dr. Haruhiko Fukuda National Cancer Center Hospital Tokyo |
14:25-14:50 |
Discussion Discussant Dr. Hideo Kunitoh National Cancer Center Hospital Tokyo |
14:50 |
III-2 Adjuvant Chemotherapy in Early Stage NSCLC Chairperson Dr. Nagahiro Saijo National Cancer Center East Prof. Kohei Yokoi Nagoya University School of Medicine |
14:50-15:10 |
Title:Current US Trials in Early Stage NSCLC Speaker Prof. Joe B. Putnam Vanderbilt University Medical Center |
15:10-15:30 |
Title:Current Status of Adjuvant Chemotherapy in Early Stage NSCLC in Europe Speaker Prof. Giorgio V. Scagliotti University of Torino |
15:30-15:45 |
Title:Japanese Adjuvant Trial in Early Stage NSCLC Speaker Dr. Hirohito Tada Osaka City General Hospital |
15:45-16:15 |
Discussion Discussant Dr. Masahiro Tsuboi Tokyo Medical University |
16:15 |
III-3 Preoperative Chemotherapy in Early Stage NSCLC Chairperson Dr. Yukito Ichinose National Kyushu Cancer Center Prof. David R. Gandara University of California Davis Cancer Center |
16:15-16:30 |
Title:A Randomized Phase III Trial of Preoperative Chemotherapy vs Chemoradiotherapy for Patients with Stage IIIA ,N2 Non-small Cell Lung Cancer. A Preliminary Report. Speaker Dr. Nobuyuki Katakami Kobe City General Hospital |
16:30-16:45 |
Title:NATCH Trial Speaker Dr. Rafael Rosell Hospital Germans Trias i Pujol |
16:45-17:15 |
Discussion Discussant Dr. Takayasu Kurata Hyogo Medical Center for Adults |
17:15-17:35 |
Summary and Closing Remarks WJTOG Prof. Kazuhiko Nakagawa Kinki University School of Medicine |